RxDoctor Payments Data

Mary Britton, MD

Family Medicine · Hickory, NCNPI 1053318246

Payments from drug & device makers

$8,881in general payments, 2019–2025

Across 475 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$1K
  • AbbVie$1K
  • Sanofi-aventis U.S. LLC$1K
  • GSK$569
  • Novo Nordisk$534
  • AstraZeneca$429
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$8,72498%
  • Education$1071%
  • Other$501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,881 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$38,982
Medicare patients
99
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide121$159,175
KerendiaFinerenone153$124,228
FarxigaDapagliflozin Propanediol90$105,079
Soliqua 100-33Insulin Glargine/Lixisenatide83$94,311
EliquisApixaban63$67,800
RybelsusSemaglutide31$43,276
JanuviaSitagliptin Phosphate20$22,309
Repatha SureclickEvolocumab30$22,182
JardianceEmpagliflozin13$17,647
VascepaIcosapent Ethyl22$14,820
MyrbetriqMirabegron15$14,649
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$13,568
TrulicityDulaglutide13$13,308
Repatha SyringeEvolocumab11$10,649
LinzessLinaclotide14$10,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$534$202,451152 claims
BayerKerendia$1,318$124,228153 claims
AstraZenecaFarxiga, Symbicort$429$110,638108 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$1,076$94,31183 claims
PfizerEliquis$400$67,80063 claims
MerckJanuvia$96$22,30920 claims
Astellas Pharma US IncMyrbetriq, Veozah$269$21,79928 claims
Boehringer IngelheimJardiance$134$17,64713 claims
AbbVieLinzess, Synthroid$1,209$15,80570 claims
GSKTrelegy Ellipta$569$13,56816 claims
Lilly USA, LLCTrulicity$409$13,30813 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$41$6,15415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →